GPR15-guided CD8⁺ T regulatory cells control intestinal inflammation

Researchers identified GPR15-guided CD8+ T regulatory cells as key controllers of intestinal inflammation in a study published online in Nature on June 8, 2026. These specific T cells, identified by the GPR15 receptor, play a crucial role in maintaining gut health by suppressing excessive immune responses. The study demonstrated that the presence and function of these GPR15+ CD8+ T cells are essential for preventing the development of inflammatory bowel diseases. When these cells are absent or dysfunctional, the immune system can overreact, leading to chronic inflammation in the intestines. The findings offer a new therapeutic target for treating conditions like Crohn's disease and ulcerative colitis, which affect millions worldwide. By understanding how GPR15+ CD8+ T regulatory cells operate, scientists can explore ways to enhance their activity to restore immune balance in the gut. This research opens avenues for developing novel immunotherapies aimed at modulating these specific T cell populations to alleviate intestinal inflammation and improve patient outcomes. The implications extend to a broader understanding of T cell subsets and their specialized roles in maintaining tissue homeostasis.